DE69621791D1 - Verfahren zur bestimmung von crohn's krankheit und colitis ulcerosa - Google Patents
Verfahren zur bestimmung von crohn's krankheit und colitis ulcerosaInfo
- Publication number
- DE69621791D1 DE69621791D1 DE69621791T DE69621791T DE69621791D1 DE 69621791 D1 DE69621791 D1 DE 69621791D1 DE 69621791 T DE69621791 T DE 69621791T DE 69621791 T DE69621791 T DE 69621791T DE 69621791 D1 DE69621791 D1 DE 69621791D1
- Authority
- DE
- Germany
- Prior art keywords
- crohn
- disease
- determining
- ulcerative colitis
- measles virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/165—Mumps or measles virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
- Electrotherapy Devices (AREA)
- Selective Calling Equipment (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9506298.0A GB9506298D0 (en) | 1995-03-28 | 1995-03-28 | Diagnostic system |
PCT/GB1996/000706 WO1996030544A1 (en) | 1995-03-28 | 1996-03-22 | Diagnostic and therapeutic system for crohn's disease and colitia ulcerosa |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69621791D1 true DE69621791D1 (de) | 2002-07-18 |
Family
ID=10772018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69621791T Expired - Lifetime DE69621791D1 (de) | 1995-03-28 | 1996-03-22 | Verfahren zur bestimmung von crohn's krankheit und colitis ulcerosa |
Country Status (10)
Country | Link |
---|---|
US (1) | US6309819B1 (de) |
EP (1) | EP0817864B1 (de) |
JP (1) | JPH11502707A (de) |
AT (1) | ATE219149T1 (de) |
AU (1) | AU701316B2 (de) |
CA (1) | CA2216807A1 (de) |
DE (1) | DE69621791D1 (de) |
GB (2) | GB9506298D0 (de) |
HK (1) | HK1002983A1 (de) |
WO (1) | WO1996030544A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2325856A (en) * | 1997-06-05 | 1998-12-09 | Royal Free Hosp School Med | Pharmaceutical composition for treatment of MMR virus mediated disease comprising a transfer factor obtained from the dialysis of virus-specific lymphocytes |
GB2347742B (en) * | 1997-06-05 | 2001-11-07 | Royal Free Hosp School Med | Pharmaceutical composition for RBD |
GB9717972D0 (en) * | 1997-08-22 | 1997-10-29 | Amersham Int Ltd | Labelling composition and method |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4871759A (en) | 1973-06-18 | 1989-10-03 | Mercer James B | Method of treatment of mesenteric adenitis |
-
1995
- 1995-03-28 GB GBGB9506298.0A patent/GB9506298D0/en active Pending
-
1996
- 1996-03-22 EP EP96908202A patent/EP0817864B1/de not_active Expired - Lifetime
- 1996-03-22 US US08/913,982 patent/US6309819B1/en not_active Expired - Fee Related
- 1996-03-22 WO PCT/GB1996/000706 patent/WO1996030544A1/en active IP Right Grant
- 1996-03-22 AT AT96908202T patent/ATE219149T1/de not_active IP Right Cessation
- 1996-03-22 JP JP8529060A patent/JPH11502707A/ja active Pending
- 1996-03-22 CA CA002216807A patent/CA2216807A1/en not_active Abandoned
- 1996-03-22 DE DE69621791T patent/DE69621791D1/de not_active Expired - Lifetime
- 1996-03-22 AU AU51531/96A patent/AU701316B2/en not_active Ceased
- 1996-03-22 GB GB9606038A patent/GB2300259B/en not_active Expired - Fee Related
-
1998
- 1998-03-13 HK HK98102097A patent/HK1002983A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GB2300259B (en) | 1999-06-23 |
JPH11502707A (ja) | 1999-03-09 |
WO1996030544A1 (en) | 1996-10-03 |
EP0817864B1 (de) | 2002-06-12 |
ATE219149T1 (de) | 2002-06-15 |
US6309819B1 (en) | 2001-10-30 |
GB2300259A (en) | 1996-10-30 |
EP0817864A1 (de) | 1998-01-14 |
AU701316B2 (en) | 1999-01-28 |
GB9506298D0 (en) | 1995-05-17 |
AU5153196A (en) | 1996-10-16 |
HK1002983A1 (en) | 1998-09-30 |
CA2216807A1 (en) | 1996-10-03 |
GB9606038D0 (en) | 1996-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100441700C (zh) | 有效检测丙型肝炎病毒(hcv)的寡核苷酸引物及其应用方法 | |
Tam et al. | Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution | |
Klimstra et al. | The furin protease cleavage recognition sequence of Sindbis virus PE2 can mediate virion attachment to cell surface heparan sulfate | |
Gottlieb et al. | Studies on macrophage RNA involved in antibody production. | |
Vey et al. | Proteolytic processing of human cytomegalovirus glycoprotein B (gpUL55) is mediatedby the human endoprotease furin | |
DE69332642D1 (de) | Methoden zur detektion von mikrometastasen bei prostata-krebs | |
Dhar et al. | Nucleotide sequence of the DNA replication origin for human papovavirus BKV: sequence and structural homology with SV40 | |
TR199800613A1 (xx) | Nezle A��s�. | |
HU9300398D0 (en) | Oligo-nucleotides influencing effect of infection by cyto-megalo virus | |
ES2013346A6 (es) | Metodos para producir secuencias y moleculas de adn recombinante, asi como proteinas t4 solubles. | |
ATE419368T1 (de) | System zum transfer und zur expression von heterologen genen ins knochenmark in vivo | |
ATE121794T1 (de) | Verfahren zum nachweis des karzinogenen menschlichen papillomavirus. | |
Scolnick et al. | Characterizatiion of rat genetic sequences of Kirsten sarcoma virus: distinct class of endogenous rat type C viral sequences | |
Hayashi et al. | Elucidation of a conserved RNA stem-loop structure in the packaging signal of human immunodeficiency virus type 1 | |
HK1042323A1 (en) | Identification of microorganisms causing acute respiratory tract infections (ari) | |
Tooker et al. | Semliki Forest virus multiplication in clones of Aedes albopictus cells | |
Reis et al. | Recombinant envelope protein (rgp90) ELISA for equine infectious anemia virus provides comparable results to the agar gel immunodiffusion | |
HUP9901005A2 (hu) | Herpeszvírusok RFHV/KSHV-alcsaládjába tartozó vírusokból származó glikoprotein-B | |
ATE219149T1 (de) | Verfahren zur bestimmung von crohn's krankheit und colitis ulcerosa | |
Omar et al. | Syncytium Formation and Inhibition in Semliki-Forest-Virus-Infected Aedes Albopictus Cells at Low pH | |
WO1996040764A3 (en) | Nucleotide and amino acid sequences of hypervariable region 1 of the envelope 2 gene of hepatitis c virus | |
Zampino et al. | Hepatitis G virus/GBV‐C persistence: absence of hypervariable E2 region and genetic analysis of viral quasispecies in serum and lymphocytes | |
Polyak et al. | Comparison of amplification enzymes for hepatitis C virus quasispecies analysis | |
HUP0200320A2 (hu) | Macskaeredetű CD28-at, CD80-at, CD86-ot vagy CTL4-A-t expresszáló rekombináns vírusok és alkalmazásuk | |
WO2003023027A3 (de) | Tt-virus-sequenzen in menschlichen tumorgeweben, mittel zu deren nachweis sowie tumortherapie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |